• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术在间变性甲状腺癌管理中的重要作用。

The important role of operations in the management of anaplastic thyroid carcinoma.

作者信息

Sugino Kiminori, Ito Koichi, Mimura Takashi, Nagahama Mitsuji, Fukunari Nobuhiro, Kubo Atsushi, Iwasaki Hiroyuki, Ito Kunihiko

机构信息

Surgical Division, Ito Hospital, The Department of Radiology, Keio University School of Medicine, Tokyo, Japan.

出版信息

Surgery. 2002 Mar;131(3):245-8. doi: 10.1067/msy.2002.119936.

DOI:10.1067/msy.2002.119936
PMID:11894027
Abstract

BACKGROUND

Anaplastic thyroid carcinoma is a rare and highly lethal neoplasm. We investigated whether operations have an impact on the survival of patients who have anaplastic carcinoma without distant metastasis.

METHODS

Between 1989 and 1999, 40 consecutive patients with anaplastic carcinoma, without distant metastasis at the time of presentation or during local treatment, were reviewed. The cumulative survival rates and 1-year survival rates were compared.

RESULTS

Eleven patients had a small focus of anaplastic carcinoma in a differentiated carcinoma, and 29 patients had ordinary anaplastic thyroid carcinoma. Surgical debulking was performed in 26 patients. Radiotherapy was used for 31 patients and chemotherapy for 19 patients. The 1-year survival rates of the patients with incidental anaplastic carcinoma, ordinary anaplastic carcinoma who underwent operations, and ordinary anaplastic carcinoma who did not undergo operations were 73%, 60%, and 21%, respectively. A significantly higher cumulative survival rate was observed in patients with incidental anaplastic carcinoma than in those with ordinary anaplastic carcinoma. A significantly better outcome was obtained by surgical debulking of ordinary anaplastic carcinoma.

CONCLUSIONS

Patients with incidental anaplastic carcinoma tended to have a good outcome, but some had a poor prognosis. Surgical debulking improved the outcome of patients with ordinary anaplastic carcinoma.

摘要

背景

间变性甲状腺癌是一种罕见且致死率很高的肿瘤。我们研究了手术对无间远处转移的间变性甲状腺癌患者生存率的影响。

方法

回顾了1989年至1999年间连续收治的40例间变性甲状腺癌患者,这些患者在就诊时或局部治疗期间均无间远处转移。比较了累积生存率和1年生存率。

结果

11例患者在分化型甲状腺癌中存在小灶间变性癌,29例患者为普通间变性甲状腺癌。26例患者接受了减瘤手术。31例患者接受了放疗,19例患者接受了化疗。偶然发现的间变性癌患者、接受手术的普通间变性癌患者和未接受手术的普通间变性癌患者的1年生存率分别为73%、60%和21%。偶然发现的间变性癌患者的累积生存率显著高于普通间变性癌患者。普通间变性癌患者通过减瘤手术获得了显著更好的预后。

结论

偶然发现的间变性癌患者预后往往较好,但部分患者预后较差。减瘤手术改善了普通间变性癌患者的预后。

相似文献

1
The important role of operations in the management of anaplastic thyroid carcinoma.手术在间变性甲状腺癌管理中的重要作用。
Surgery. 2002 Mar;131(3):245-8. doi: 10.1067/msy.2002.119936.
2
Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.间变性甲状腺癌:两组常规放疗与超分割放化疗的比较。
Am J Clin Oncol. 2002 Oct;25(5):442-6. doi: 10.1097/01.COC.0000023060.34146.B3.
3
Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.间变性甲状腺癌患者的早期手术与生存情况:对1999年至2012年间转诊至单一机构的一组病例的分析
Thyroid. 2014 Nov;24(11):1600-6. doi: 10.1089/thy.2014.0004. Epub 2014 Sep 5.
4
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.间变性甲状腺癌:过去5年转诊至单一机构的30例连续患者的临床结局。
Eur J Endocrinol. 2007 Apr;156(4):425-30. doi: 10.1530/EJE-06-0677.
5
[Undifferentiated carcinoma of the thyroid].
Tumori. 2003 Jul-Aug;89(4 Suppl):205-6.
6
The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma.
Ann Surg Oncol. 2002 Jan-Feb;9(1):57-64. doi: 10.1245/aso.2002.9.1.57.
7
Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group.多柔比星、超分割放疗与手术联合治疗间变性甲状腺癌。两项方案报告。瑞典间变性甲状腺癌研究组
Cancer. 1994 Aug 15;74(4):1348-54. doi: 10.1002/1097-0142(19940815)74:4<1348::aid-cncr2820740427>3.0.co;2-d.
8
Anaplastic cancer, lymphoma, and metastases of the thyroid gland.间变性癌、淋巴瘤及甲状腺转移瘤。
Surg Oncol Clin N Am. 1998 Oct;7(4):707-20.
9
Anaplastic carcinoma of the thyroid.甲状腺未分化癌
Am J Surg. 1999 Apr;177(4):337-9. doi: 10.1016/s0002-9610(99)00052-5.
10
A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.一种新型化疗联合低剂量顺铂、5-氟尿嘧啶和阿霉素治疗间变性甲状腺癌的初步报告。
Jpn J Clin Oncol. 2011 Sep;41(9):1074-8. doi: 10.1093/jjco/hyr095. Epub 2011 Jul 26.

引用本文的文献

1
The role of surgery for anaplastic thyroid carcinoma in the era of targeted therapeutics: A scoping review.靶向治疗时代手术在间变性甲状腺癌治疗中的作用:一项范围综述。
Laryngoscope Investig Otolaryngol. 2023 Oct 17;8(6):1673-1684. doi: 10.1002/lio2.1172. eCollection 2023 Dec.
2
Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma.镓-68前列腺特异性膜抗原-HBED-CC正电子发射断层扫描/计算机断层扫描在间变性甲状腺癌中的应用
Indian J Nucl Med. 2022 Oct-Dec;37(4):310-317. doi: 10.4103/ijnm.ijnm_21_22. Epub 2022 Dec 2.
3
Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients.
年龄影响间变性甲状腺癌患者的预后。
Front Endocrinol (Lausanne). 2021 Jul 27;12:704596. doi: 10.3389/fendo.2021.704596. eCollection 2021.
4
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.2021 年美国甲状腺协会甲状腺间变性癌患者管理指南。
Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944.
5
Airway management, symptom relief and best supportive care in anaplastic thyroid cancer.间变性甲状腺癌的气道管理、症状缓解及最佳支持治疗
Curr Opin Otolaryngol Head Neck Surg. 2020 Apr;28(2):74-78. doi: 10.1097/MOO.0000000000000619.
6
The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.间变性甲状腺癌的发病率及生存分析:一项监测、流行病学和最终结果(SEER)数据库分析
Am J Transl Res. 2019 Sep 15;11(9):5888-5896. eCollection 2019.
7
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy.STAT3:化疗和放疗抵抗的新型分子介质。
Cancers (Basel). 2014 Sep 29;6(4):1986-2011. doi: 10.3390/cancers6041986.
8
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?过去20年间间变性甲状腺癌患者的治疗:是否取得了任何进展?
Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1553-67. doi: 10.1007/s00405-014-3108-1. Epub 2014 Jun 3.
9
Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma.风险分组对间变性甲状腺癌患者治疗决策的影响。
Eur Arch Otorhinolaryngol. 2015 Apr;272(4):985-993. doi: 10.1007/s00405-014-2937-2. Epub 2014 Apr 10.
10
Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.中国单中心经验:间变性甲状腺癌的治疗和预后。
PLoS One. 2013 Nov 5;8(11):e80011. doi: 10.1371/journal.pone.0080011. eCollection 2013.